2 BLEND CJC-1295 ( NO DAC )- 5MG / IPAMORELIN – 5MG (WITH BACTERIOSTATIC WATER) – GENLABS

The  Genlabs CJC-1295 (No DAC) and Ipamorelin blend is a widely studied peptide combination known for its potential to stimulate the natural release of growth hormone (GH) in the body. This synergistic duo is commonly used in research related to anti-aging, muscle growth, recovery, and fat metabolism. Together, these peptides provide a targeted, physiological approach to growth hormone stimulation with minimal side effects.

How It Works?

Genlabs CJC-1295 (No DAC) is a tetrasubstituted analog of Growth Hormone-Releasing Hormone (GHRH) that binds to GHRH receptors in the pituitary gland. The No DAC version has a shorter half-life, resulting in more natural, pulsatile GH release, similar to the body’s own rhythm.

Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP) that binds to ghrelin receptors, stimulating GH release without significantly affecting cortisol or prolactin levels. When combined with CJC-1295 (No DAC), Ipamorelin works synergistically to amplify GH secretion by targeting different receptor pathways.

Dosage :

Typical Dose: 100mcg to 300mcg of each peptide (CJC-1295 No DAC and Ipamorelin), administered 1–3 times daily.

Administration Method: Subcutaneous injection.

Benefits :

• Enhanced natural growth hormone secretion
• Improved recovery from physical activity
• Support for lean muscle development
• Reduced body fat through improved metabolism
• Better sleep quality and cellular regeneration
• Anti-aging support through increased IGF-1 levels
• Low risk of desensitization compared to traditional GHRPs

Side Effects :

While both peptides are generally well-tolerated, some reported side effects include:

• Mild irritation or redness at injection site
• Temporary flushing or lightheadedness
• Headache or fatigue in sensitive subjects
• Nausea (rare and typically dose-dependent)

Conclusion :

The CJC-1295 (No DAC) and Ipamorelin blend offers a powerful and synergistic approach to stimulating natural growth hormone release. Its effectiveness, safety profile, and physiological compatibility make it an ideal choice for researchers exploring the potential benefits of enhanced GH secretion.